Panacea Journal of Medical Sciences

---

Evaluation of interleukin-6 and C - reactive protein as a inflammatory mediators in type 2 diabetic subjects in Indian population of Bhopal

Full Text PDF Share on Facebook Share on Twitter

---

Original Article

Author Details : Prashant J Hisalkar, Anupama Patne, Akanksha Dubey*

Volume : 12, Issue : 2, Year : 2022

Article Page : 340-344

https://10.18231/j.pjms.2022.064

Suggest article by email

---

Abstract

Background: India leads the world with the largest number of Diabetic subjects, hence can be called as Diabetic Capital of World. Type 2 Diabetes Mellitus (T2DM) is a metabolic disorder resulting from insulin insufficiency or function. The researches in past decade have revealed a critical link between metabolic disorders and inflammation which leads to a concept called metaflammation. The linkage of inflammation and type 2 diabetes mellitus (T2DM) has been extensively investigated for over a decade. The main objective of the study is to assess inflammatory markers in T2DM subjects by measuring cytokines and acute phase proteins and its comparison with healthy controls.
Materials and Methods: Total 100 subjects were studied which were divided into two groups of 100 of Diabetic cases and 100 Healthy controls after defining proper inclusion and exclusion criteria. Gender wise distribution was also done. FPG, 2H-PG, HbA1C and CRP were estimated on fully automated analyzers while IL-6 was estimated by ELISA.
Results: The result had shown that cases have significantly elevated IL-6 and CRP when compared to age and sex matched healthy controls with p<0> Conclusion: We can conclude that in developing countries like India estimation of inflammatory markers along with glycemic markers can predict secondary complications of disease.
 

Keywords: Type 2 Diabetes Mellitus, IL­6, HbA1C, Glycemic Control, CRP, Inflammation, Metaflammation

How to cite : Hisalkar P J, Patne A, Dubey A, Evaluation of interleukin-6 and C - reactive protein as a inflammatory mediators in type 2 diabetic subjects in Indian population of Bhopal. Panacea J Med Sci 2022;12(2):340-344

Copyright © 2022 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)